Law360, New York (September 10, 2009) -- The federal judge overseeing a bellwether Fosamax trial is giving jurors a chance to simmer down, as tensions run high in their debate over whether Merck & Co. should be held responsible for the jaw deterioration of a woman who took the osteoporosis drug for years.
On Wednesday, Judge John Keenan of the U.S. District Court for the Southern District of New York opted to give jurors in the case brought by Shirley Boles a daylong...
